查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球柳葉刀市場
市場調查報告書
商品編碼
1166528

2022-2029 年全球柳葉刀市場

Global Lancets Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

在預測期內（2022-2029 年），"柳葉刀"的全球市場規模預計將以 11.66% 的複合年增長率增長。

柳葉刀是用塑料塗層的手術鋼製成的尖頭，用於刺穿手指（或其他身體部位）的皮膚以獲取血液樣本。 它還用於做小切口以引流膿腫和膿腫。

市場動態

在預測期內，糖尿病和傳染病患者數量的增加導致柳葉刀市場的增長。

在預測期內，糖尿病和傳染病患病率的上升正在推動全球柳葉刀市場的增長。

在預測期內，全球糖尿病患病率和傳染病的上升正在推動全球柳葉刀市場的增長。 例如，世界衛生組織 (WHO) 報告稱，結核病是全球第 13 大死因，也是僅次於 COVID-19 的第二大傳染病（但被 HIV/AIDS 超越）。 據世界衛生組織報告，2020年全球約有1000萬人感染結核病，其中男性約560萬人，女性約330萬人，兒童約110萬人。 摘自 TBFACT 的“結核病統計”。 在 ORG 中，受結核病影響最嚴重的 30 個國家佔 2020 年新增病例的 86%。 印度佔總數的三分之二，其次是中國、印度尼西亞、菲律賓、巴基斯坦、尼日利亞、孟加拉國和南非

此外，根據世界衛生組織 (WHO) 全球結核病報告，歐洲 (2.3%)、美國 (3.0%)、東地中海 (8.3%)、2021 年結核病病例數將增加， %)，西太平洋 (18%)、非洲 (25%) 和東南亞 (43%) 更高。 同樣，根據世界衛生組織 (WHO) 的數據，撒哈拉以南非洲繼續承受著瘧疾的負擔，約佔病例的 95% 和死亡的 96%。 因此，預計傳染病病例的增加將推動市場的高速增長。

無需刺破皮膚即可測量血液參數的先進產品的推出對全球柳葉刀市場的增長構成了重大威脅。

然而，開發無需刺破皮膚即可提供血液參數的新產品對全球柳葉刀市場構成了重大威脅。 例如，雅培 (Abbott) 的 FreeStyle Libre 是一款突破性產品，可讓您在不刺破手指的情況下跟蹤血糖水平。 這是一個基於傳感器的葡萄糖監測系統，帶有讀取器和傳感器。

COVID-19 的影響。

COVID-19 大流行對全球柳葉刀市場產生了重大影響。 對用於 COVID-19 抗體檢測和血液中抗體血清學檢測的柳葉刀的需求不斷增長。 為檢測 COVID-19 抗體，醫護人員通常會用柳葉刀刺破手指或從靜脈抽血來採集血樣。 大量的人感染了 COVID-19，對血清學檢測和配套的柳葉刀產生了強烈的需求，這對全球柳葉刀市場產生了積極影響。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 傳染病患者增加
      • 糖尿病患者增加
    • 約束因素
      • 替代產品的發布
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按類型

  • 個人柳葉刀
  • 安全柳葉刀
    • 側鍵柳葉刀
    • 按鈕式柳葉刀
    • 壓力柳葉刀
    • 其他

第八章應用

  • 血紅蛋白測試
  • 葡萄糖測試
  • 凝血試驗
  • 其他

第 9 章最終用戶

  • 醫院和診所
  • 家庭護理
  • 診斷中心/病理實驗室
  • 其他

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準

第12章公司簡介

  • Abbott Laboratories
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • B. Braun Melsungen
  • BD
  • Roche Diagnostics
  • HTL-Strefa S.A
  • Intuity Medical
  • Terumo Corporation
  • Medline Industries
  • Arkray
  • Owen Mumford

第13章 DataM

簡介目錄
Product Code: DMMD1251

Market Overview

The global lancets market size was valued around US$ YY million in 2021 and is expected to reach US$ YY million by 2029, growing at a CAGR of 11.66% during the forecast period (2022-2029).

A lancet is a sharp pointy piece of surgical steel sheathed in plastic, employed to pierce the skin on one's finger (or other body parts) to get a blood sample. Other lancets are used for making small incisions, as in the draining of boils and abscesses.

Market Dynamics

The growing number of diabetes cases and infectious diseases are fueling the global lancets market in the forecast period.

Growing diabetes and infectious disease cases are boosting the global lancet market growth during the forecast period.

The growing number of diabetes cases and infectious diseases worldwide are accelerating the global lancets market growth during the forecast period. For instance, according to the World Health Organization(WHO) report, Tuberculosis is the world's 13th leading reason of death and the second leading infectious disease, following only COVID-19 (but ahead of HIV/AIDS). Around 10 million people suffered from Tuberculosis globally in 2020, according to the WHO report, including around 5.6 million men, 3.3 million women, and 1.1 million children. From the TB Statistics by TBFACT. ORG, the 30 most-affected countries by Tuberculosis, accounted for 86% of new cases in 2020. India had two-thirds of the total, followed by China, Indonesia, the Philippines, Pakistan, Nigeria, Bangladesh, and South Africa

Moreover, according to the World Health Organization Global Tuberculosis Report, the lesser of tuberculosis cases were in the World Health Organization (WHO) regions of Europe (2.3%), the Americas (3.0%), Eastern Mediterranean (8.3%) and the majority numbers of tuberculosis cases were found in Western Pacific (18%), Africa (25%) and South-East Asia (43%) for 2021. Likewise, according to World Health Organization (WHO) data, Sub-Saharan Africa continued to bear the burden of malaria, accounting for around 95% of cases and 96% of deaths. Therefore, the climbing cases of infectious diseases are anticipated to boost the high market growth.

Introducing advanced products that can measure blood parameters without pricking skin is a major threat to the global lancets market growth.

However, developing new products that can provide the blood parameters without pricking is a major threat to the global lancet market. For instance, Abbott's FreeStyle Libre is a revolutionary product that helps to track glucose levels without fingerpicks. It is a sensor-based glucose monitoring system with a reader and a sensor.

COVID-19 Impact.

The COVID-19 pandemic has impacted the global lancets market significantly. There was an increased demand for the lancets to perform COVID-19 Antibody or serology tests which look for antibodies in the blood. For conducting an antibody test for COVID-19, a healthcare professional normally withdraws a blood sample, commonly by a finger prick with a lancet or drawing blood from a vein. Then the sample is tested to determine whether it contains antibodies against the COVID-19 virus since a large population was infected with COVID-19, creating a great demand for serological testing and thereby lancets, positively impacting the global lancets market.

Segment Analysis

The blood glucose testing segment is estimated to dominate the market throughout the forecast period (2022-2029).

The blood glucose testing segment is predicted to grow at the highest CAGR during the forecast period (2022-2029). Owing to the rising cases of diabetes globally, for instance, according to the International Diabetic Federation statistics from 2021, approximately 537 million adults (20-79 years) are living with diabetes, and the number is presumed to attain around 643 million by 2030. It will be about 783 million by 2045. Currently, 3 out of 4 adults from low- and middle-income countries have diabetes. Still, around 1 in 2, accounting for about 240 million adults living with diabetes, are undiagnosed. Diabetes claimed about 6.7 million deaths and USD 966 billion in health expenditure, 9% of total spending on adults. Also, 541 million adults are at increased risk of developing type 2 diabetes.

Furthermore, growing awareness about diabetes contributes to the growth of the glucose testing segment at a high CAGR, as many government and non-government organizations are working to spread awareness about diabetes and the benefits of regular blood glucose level monitoring. Therefore, from the above mention data and supporting statistics, it is anticipated that the blood glucose testing segment will dominate the global lancet market throughout the forecast period (2022-2029).

Geographical Analysis

The North American region holds the largest global lancets market share.

North America holds most of the lancet market. It is presumed to show a similar trend in the forecasted years (2022-2029), Owing to the steps taken by the government addressing diabetes and the growing cases of diabetes in this region. For instance, according to the Proclamation on National Diabetes by THE WHITE HOUSE in OCTOBER 2022, In August, after decades of big pharmaceutical companies blocking meaningful change, the president of the United States signed the Inflation Reduction Act into law, which caps the cost of a month's supply of insulin at $35 per prescription for over 3 million seniors on Medicare. Moreover, congress has significantly expanded its backing of diabetes-related biomedical research, specifically at the National Institutes of Health. For example, a controlled trial of glucose control in type 1 diabetes demonstrated the effectiveness of blood sugar control in preventing eye, kidney, and nerve complications. Diabetic Retinopathy Study and the Early Treatment Diabetic Retinopathy Study demonstrated the value of laser photocoagulation to prevent the progression of diabetic eye disease and establish diabetes research and training centers across the country.

Furthermore, according to the International Diabetes Federation, North America and Caribbean Region had 51 million adults (20-79) with diabetes in 2021, and it is predicted to be 57 million by 2030 and 63 million by 2045. Around 12 million people with diabetes are undiagnosed. Thus, the above data indicate that North America will hold most of the lancet market throughout the forecast period.

Competitive Landscape

The lancets market is moderately competitive due to opportunities for new market players to enter. Some of the key players hold the majority of the market share. Some key players are Abbott Laboratories, B. Braun Melsungen, BD, Roche Diagnostics, HTL-Strefa S.A, Intuity Medical, Terumo Corporation, Medline Industries, Arkray and Owen Mumford. These key players hold the major share of the market through various market tactics such as innovations, product launches, collaborations, acquisitions, and alliances. For instance, in October 2021, Roche Diabetic Care collaborated with Zur Rose, a European digital healthcare ecosystem provider, to improve day-to-day therapy management and address the requirements of 60 million European diabetic patients.

Abbott Diabetic Care

Overview:

Abbott Diabetic Care, a global leader in diabetes care, was founded in 1995 and had since been constantly working to deliver the highest quality products and unwavering support to our customers.

Product Portfolio:

Abbott Diabetic Care's product portfolio contains FREESTYLE LANCETS: FreeStyle Lancets are constructed from thin, 28 gauge, sterilized stainless steel that provides a secure lancing experience. For use with FreeStyle Lancing Device I or II and conforms to almost all other lancing devices.

The global lancets market report would provide access to approximately 40 + market data tables, 45 + figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Cases of Infectious Diseases
      • 4.1.1.2. Growing Cases of Diabetes
    • 4.1.2. Restraints
      • 4.1.2.1. Substituent Product Launches
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Personal Lancets
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Safety Lancets
    • 7.3.1. Side Button Lancets
    • 7.3.2. Push Button Lancets
    • 7.3.3. Pressure Activated Lancets
    • 7.3.4. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Hemoglobin Testing
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Glucose Testing
  • 8.4. Coagulation Testing
  • 8.5. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals & Clinics
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Home Care
  • 9.4. Diagnostic Centers and Pathology Laboratories
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Company Profiles

  • 12.1. Abbott Laboratories
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. B. Braun Melsungen
  • 12.3. BD
  • 12.4. Roche Diagnostics
  • 12.5. HTL-Strefa S.A
  • 12.6. Intuity Medical
  • 12.7. Terumo Corporation
  • 12.8. Medline Industries
  • 12.9. Arkray
  • 12.10. Owen Mumford

LIST NOT EXHAUSTIVE

13. DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us